Yes, this is a concern. However, as noted by
John Maraganor of Alnylam (a company that RH has hinted might be a template for the development of Pyctx), the FDA is going through a period of rebuilding. Hopefully it can RE-staff with quality people.
Every organisation contains some “drones”. Let’s hope most of those cut belonged in that category and they can “build back better”.
As an aside, will Pyctx lodge with the TGA here and the FDA equivalent in Europe?
Happy Easter to all
FHC
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $45.30K | 38.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |